Relationship between Severity of Visual Field Loss at Presentation and Rate of Visual Field Progression in Glaucoma

To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 118; no. 2; pp. 249 - 253
Main Authors Rao, Harsha L., Kumar, Addepalli U., Babu, Jonnadula G., Senthil, Sirisha, Garudadri, Chandra S.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.02.2011
Elsevier
Subjects
Online AccessGet full text
ISSN0161-6420
1549-4713
1549-4713
DOI10.1016/j.ophtha.2010.05.027

Cover

Loading…
Abstract To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > −6 dB), moderate (MD ≤ −6 to ≥ −12 dB) or severe (MD < −12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Relationship between severity of VF loss at presentation and ROP. The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = −0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = −0.05; P = 0.61). In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. Proprietary or commercial disclosure may be found after the references.
AbstractList To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.PURPOSETo evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.Clinic-based, retrospective study.DESIGNClinic-based, retrospective study.We included 512 eyes of 310 primary glaucoma patients.PARTICIPANTSWe included 512 eyes of 310 primary glaucoma patients.We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > -6 dB), moderate (MD ≤ -6 to ≥ -12 dB) or severe (MD < -12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP.METHODSWe analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > -6 dB), moderate (MD ≤ -6 to ≥ -12 dB) or severe (MD < -12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP.Relationship between severity of VF loss at presentation and ROP.MAIN OUTCOME MEASURESRelationship between severity of VF loss at presentation and ROP.The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = -0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = -0.05; P = 0.61).RESULTSThe median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = -0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = -0.05; P = 0.61).In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage.CONCLUSIONSIn early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage.
Purpose To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Design Clinic-based, retrospective study. Participants We included 512 eyes of 310 primary glaucoma patients. Methods We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > −6 dB), moderate (MD ≤ −6 to ≥ −12 dB) or severe (MD < −12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Main Outcome Measures Relationship between severity of VF loss at presentation and ROP. Results The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD ( P = 0.02) and for every year of increasing age ( P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = −0.16; P <0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = −0.05; P = 0.61). Conclusions In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. Financial Disclosure(s) Proprietary or commercial disclosure may be found after the references.
To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > -6 dB), moderate (MD ≤ -6 to ≥ -12 dB) or severe (MD < -12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Relationship between severity of VF loss at presentation and ROP. The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = -0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = -0.05; P = 0.61). In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage.
To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective study. We included 512 eyes of 310 primary glaucoma patients. We analyzed the VFs of all subjects of primary glaucoma who had >5 VFs between 1989 and 2008. Based on the mean deviation (MD), we classified the VF loss as mild (MD > −6 dB), moderate (MD ≤ −6 to ≥ −12 dB) or severe (MD < −12 dB). Guided Progression Analysis software which gives the rate of progression (ROP) of Visual Field Index per year was used to assess the ROP. Relationship between severity of VF loss at presentation and ROP. The median duration of follow-up was 6.8 years. The ROP increased (worsened) by 0.02% per year for every dB worsening of MD (P = 0.02) and for every year of increasing age (P = 0.001). Association between MD and ROP showed a significant positive relationship in mild (β = 0.18; P = 0.001) and a significant negative relationship in severe (β = −0.16; P<0.001) VF loss category. Association between MD and ROP was not significant in the moderate VF loss category (β = −0.05; P = 0.61). In early stages of glaucoma, the ROP worsened as the severity increased, but, in later stages of the disease, ROP became smaller as the severity increased. There is a need for better methods to detect progression in eyes with severe glaucomatous damage. Proprietary or commercial disclosure may be found after the references.
Author Garudadri, Chandra S.
Babu, Jonnadula G.
Rao, Harsha L.
Senthil, Sirisha
Kumar, Addepalli U.
Author_xml – sequence: 1
  givenname: Harsha L.
  surname: Rao
  fullname: Rao, Harsha L.
  email: harshabl.76@gmail.com
– sequence: 2
  givenname: Addepalli U.
  surname: Kumar
  fullname: Kumar, Addepalli U.
– sequence: 3
  givenname: Jonnadula G.
  surname: Babu
  fullname: Babu, Jonnadula G.
– sequence: 4
  givenname: Sirisha
  surname: Senthil
  fullname: Senthil, Sirisha
– sequence: 5
  givenname: Chandra S.
  surname: Garudadri
  fullname: Garudadri, Chandra S.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23817831$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20728941$$D View this record in MEDLINE/PubMed
BookMark eNqVkl9rFDEUxYNU7Lb6DUTyIj7NmmSS-SMiSLFVWLC06mvIZO64WbPJNslU9tub6WwRFCk-BS6_c8I9556gI-cdIPSckiUltHq9WfrdOq3VkpE8ImJJWP0ILajgbcFrWh6hRcZoUXFGjtFJjBtCSFWV_Ak6ZqRmTcvpAsUrsCoZ7-La7HAH6SeAw9dwC8GkPfYD_mbiqCw-N2B7vPIxYpXwZYAILt0psXI9vlIJ_qIvg_-ewThBxuELq0btt-opejwoG-HZ4T1FX88_fDn7WKw-X3w6e78qtKhEKlpR00Gzti8rOvSqFapveNlRWg1NW_V9XTMA3mloRKtIxyshoOwGziCvXZOmPEWvZt9d8DcjxCS3JmqwVjnwY5QNb3nJ6pJm8sWBHLst9HIXzFaFvbzPKQMvD4CKWtkhKKdN_M2VDa2bO6M3M6dDTirAILWZU0pBGSspkVN5ciPn8uRUniRC5vKymP8hvvd_QPZulkHO8tZAkFEbcBp6E0An2XvzvwbaGmfynj9gD3Hjx-ByT5LKyCSR19NZTVdFp4MitM0Gb_9t8PD_vwByF96b
CODEN OPHTDG
CitedBy_id crossref_primary_10_1167_iovs_18_25391
crossref_primary_10_1159_000486575
crossref_primary_10_15406_mojt_2016_02_00027
crossref_primary_10_1097_IJG_0000000000000710
crossref_primary_10_5005_jp_journals_10008_1186
crossref_primary_10_1016_j_ajo_2016_06_005
crossref_primary_10_1111_opo_13312
crossref_primary_10_1007_s00417_012_2214_2
crossref_primary_10_1016_j_ophtha_2011_09_021
crossref_primary_10_1016_j_ophtha_2011_09_022
crossref_primary_10_1007_s00417_020_05036_5
crossref_primary_10_4103_IJO_IJO_3238_23
crossref_primary_10_1097_IJG_0b013e31829484c6
crossref_primary_10_1167_iovs_65_1_30
crossref_primary_10_1016_j_ajo_2023_09_017
crossref_primary_10_1167_iovs_62_9_4
crossref_primary_10_1016_j_ajo_2024_06_017
crossref_primary_10_1038_eye_2013_294
crossref_primary_10_1097_IJG_0000000000000146
crossref_primary_10_1167_iovs_61_14_33
crossref_primary_10_1001_jamaophthalmol_2020_0647
crossref_primary_10_1136_bjophthalmol_2016_309401
crossref_primary_10_1016_j_ogla_2018_05_005
crossref_primary_10_1016_j_ajo_2012_05_025
crossref_primary_10_1016_j_optom_2014_07_009
crossref_primary_10_1136_bjophthalmol_2020_315980
crossref_primary_10_1016_j_ophtha_2017_02_027
crossref_primary_10_1038_s41433_021_01603_0
crossref_primary_10_4103_ijo_IJO_1737_22
crossref_primary_10_1038_eye_2013_285
crossref_primary_10_4103_IJO_IJO_2735_23
crossref_primary_10_1097_IJG_0000000000001985
crossref_primary_10_1371_journal_pone_0078630
crossref_primary_10_37039_1982_8551_20220102
crossref_primary_10_3390_bioengineering12030321
crossref_primary_10_1038_eye_2015_17
crossref_primary_10_3341_jkos_2024_65_7_456
crossref_primary_10_1038_eye_2013_77
crossref_primary_10_1167_iovs_18_25421
crossref_primary_10_3390_bioengineering11030250
crossref_primary_10_1097_IJG_0b013e31822e8e37
crossref_primary_10_1167_iovs_18_25140
crossref_primary_10_1136_bmjophth_2023_001575
crossref_primary_10_1097_IJG_0000000000001179
crossref_primary_10_1097_IJG_0000000000002300
crossref_primary_10_1371_journal_pone_0127233
crossref_primary_10_1016_j_ajo_2019_02_015
crossref_primary_10_1038_s41598_020_76154_7
crossref_primary_10_1155_2018_8941489
crossref_primary_10_1007_s40123_019_00222_z
crossref_primary_10_1016_j_preteyeres_2016_10_001
Cites_doi 10.1016/j.survophthal.2008.08.006
10.1001/archopht.1992.01080150079033
10.1097/ICU.0b013e3282f493b3
10.1001/archophthalmol.2009.297
10.1080/01621459.1988.10478639
10.1016/S0161-6420(03)00076-9
10.1001/archopht.121.1.48
10.1016/j.ophtha.2004.02.017
10.1007/s004170050262
10.1016/j.ajo.2007.09.038
10.1167/iovs.03-0692
10.1097/00061198-200404000-00007
10.1364/JOSAA.24.001426
10.1016/S0002-9394(00)00487-6
10.1001/archopht.118.4.481
10.1001/archopht.1982.01030030741002
10.1111/j.0006-341X.2000.00645.x
10.1038/sj.eye.6701605
10.1016/S0161-6420(01)00873-9
10.3341/kjo.2004.18.2.106
ContentType Journal Article
Copyright 2011 American Academy of Ophthalmology
American Academy of Ophthalmology
2015 INIST-CNRS
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2011 American Academy of Ophthalmology
– notice: American Academy of Ophthalmology
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ophtha.2010.05.027
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1549-4713
EndPage 253
ExternalDocumentID 20728941
23817831
10_1016_j_ophtha_2010_05_027
S0161642010006019
1_s2_0_S0161642010006019
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Hyderabad Eye Research Foundation
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFO
ACGFS
ACIUM
ACNCT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEFWE
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGQPQ
AIGII
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
C5W
CS3
DU5
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M41
MO0
N4W
N9A
NQ-
O9-
OF-
OPF
OQ~
P2P
R2-
ROL
RPZ
SDG
SEL
SES
SSZ
UHS
UNMZH
UV1
WH7
X7M
XH2
XPP
Z5R
ZGI
ZXP
ADPAM
RIG
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c565t-9571fc29d361fda95ad843b116f896dd772ee4bce859a0b4655e3bf42e1617083
ISSN 0161-6420
1549-4713
IngestDate Fri Jul 11 03:37:58 EDT 2025
Mon Jul 21 05:53:18 EDT 2025
Mon Jul 21 09:12:19 EDT 2025
Tue Jul 01 01:01:32 EDT 2025
Thu Apr 24 22:58:07 EDT 2025
Fri Feb 23 02:14:11 EST 2024
Sun Feb 23 10:19:11 EST 2025
Tue Aug 26 19:02:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Glaucoma
Protozoa
Eye disease
Prognosis
Visual field disease
Glaucoma (eye)
Visual field
Rate
Visual field defect
Evolution
Ciliata
Ophthalmology
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c565t-9571fc29d361fda95ad843b116f896dd772ee4bce859a0b4655e3bf42e1617083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20728941
PQID 849432731
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_849432731
pubmed_primary_20728941
pascalfrancis_primary_23817831
crossref_citationtrail_10_1016_j_ophtha_2010_05_027
crossref_primary_10_1016_j_ophtha_2010_05_027
elsevier_sciencedirect_doi_10_1016_j_ophtha_2010_05_027
elsevier_clinicalkeyesjournals_1_s2_0_S0161642010006019
elsevier_clinicalkey_doi_10_1016_j_ophtha_2010_05_027
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-02-01
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Ophthalmology (Rochester, Minn.)
PublicationTitleAlternate Ophthalmology
PublicationYear 2011
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Smith, Katz, Quigley (bib7) 1996; 37
Schwartz, Takamoto, Martin (bib9) 2004; 13
Nouri-Mahdavi, Hoffman, Coleman (bib21) 2004; 111
Williams (bib15) 2000; 56
(bib4) 2002; 134
Spry, Sparrow, Diamond, Harris (bib20) 2005; 19
Coleman, Miglior (bib2) 2008; 53
Stewart, Kolker, Sharpe (bib3) 2000; 130
Bengtsson, Patella, Heijl (bib19) 2009; 127
Wilson, Walker, Dueker, Crick (bib22) 1982; 100
Leske, Heijl, Hussein (bib5) 2003; 121
Rivera, Bell, Feldman (bib1) 2008; 19
Bengtsson, Heijl (bib12) 2008; 145
Schlottmann, De Cilla, Greenfield (bib17) 2004; 45
Rasker, van den Enden, Bakker, Hoyng (bib8) 2000; 118
Glynn, Rosner (bib14) 1992; 110
Cleveland, Devlin (bib16) 1988; 83
Lichter, Musch, Gillespie (bib6) 2001; 108
Eid, Spaeth, Bitterman, Steinmann (bib10) 2003; 110
Anderson, Patella (bib13) 1999
Suzuki, Shirato, Adachi, Hamada (bib11) 1999; 237
Hood (bib18) 2007; 24
Lee, Kim, Hong (bib23) 2004; 18
Williams (10.1016/j.ophtha.2010.05.027_bib15) 2000; 56
Bengtsson (10.1016/j.ophtha.2010.05.027_bib19) 2009; 127
Lee (10.1016/j.ophtha.2010.05.027_bib23) 2004; 18
Anderson (10.1016/j.ophtha.2010.05.027_bib13) 1999
Hood (10.1016/j.ophtha.2010.05.027_bib18) 2007; 24
Stewart (10.1016/j.ophtha.2010.05.027_bib3) 2000; 130
Glynn (10.1016/j.ophtha.2010.05.027_bib14) 1992; 110
Wilson (10.1016/j.ophtha.2010.05.027_bib22) 1982; 100
Rasker (10.1016/j.ophtha.2010.05.027_bib8) 2000; 118
Bengtsson (10.1016/j.ophtha.2010.05.027_bib12) 2008; 145
Coleman (10.1016/j.ophtha.2010.05.027_bib2) 2008; 53
Eid (10.1016/j.ophtha.2010.05.027_bib10) 2003; 110
Schlottmann (10.1016/j.ophtha.2010.05.027_bib17) 2004; 45
Nouri-Mahdavi (10.1016/j.ophtha.2010.05.027_bib21) 2004; 111
Smith (10.1016/j.ophtha.2010.05.027_bib7) 1996; 37
Rivera (10.1016/j.ophtha.2010.05.027_bib1) 2008; 19
(10.1016/j.ophtha.2010.05.027_bib4) 2002; 134
Lichter (10.1016/j.ophtha.2010.05.027_bib6) 2001; 108
Leske (10.1016/j.ophtha.2010.05.027_bib5) 2003; 121
Schwartz (10.1016/j.ophtha.2010.05.027_bib9) 2004; 13
Cleveland (10.1016/j.ophtha.2010.05.027_bib16) 1988; 83
Suzuki (10.1016/j.ophtha.2010.05.027_bib11) 1999; 237
Spry (10.1016/j.ophtha.2010.05.027_bib20) 2005; 19
22214951 - Ophthalmology. 2012 Jan;119(1):203-4; author reply 204
References_xml – volume: 121
  start-page: 48
  year: 2003
  end-page: 56
  ident: bib5
  article-title: Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial
  publication-title: Arch Ophthalmol
– volume: 111
  start-page: 1627
  year: 2004
  end-page: 1635
  ident: bib21
  article-title: Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study
  publication-title: Ophthalmology
– volume: 118
  start-page: 481
  year: 2000
  end-page: 488
  ident: bib8
  article-title: Rate of visual field loss in progressive glaucoma
  publication-title: Arch Ophthalmol
– volume: 127
  start-page: 1610
  year: 2009
  end-page: 1615
  ident: bib19
  article-title: Prediction of glaucomatous visual field loss by extrapolation of linear trends
  publication-title: Arch Ophthalmol
– volume: 13
  start-page: 120
  year: 2004
  end-page: 129
  ident: bib9
  article-title: Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma
  publication-title: J Glaucoma
– volume: 110
  start-page: 381
  year: 1992
  end-page: 387
  ident: bib14
  article-title: Accounting for the correlation between fellow eyes in regression analysis
  publication-title: Arch Ophthalmol
– volume: 37
  start-page: 1419
  year: 1996
  end-page: 1428
  ident: bib7
  article-title: Analysis of progressive change in automated visual fields in glaucoma
  publication-title: Invest Ophthalmol Vis Sci
– volume: 130
  start-page: 274
  year: 2000
  end-page: 279
  ident: bib3
  article-title: Factors associated with long-term progression or stability in primary open-angle glaucoma
  publication-title: Am J Ophthalmol
– volume: 24
  start-page: 1426
  year: 2007
  end-page: 1430
  ident: bib18
  article-title: Relating retinal nerve fiber thickness to behavioral sensitivity in patients with glaucoma: application of a linear model
  publication-title: J Opt Soc Am A Opt Image Sci Vis
– volume: 19
  start-page: 102
  year: 2008
  end-page: 106
  ident: bib1
  article-title: Risk factors for primary open angle glaucoma progression: what we know and what we need to know
  publication-title: Curr Opin Ophthalmol
– volume: 56
  start-page: 645
  year: 2000
  end-page: 646
  ident: bib15
  article-title: A note on robust variance estimation for cluster-correlated data
  publication-title: Biometrics
– volume: 134
  start-page: 499
  year: 2002
  end-page: 512
  ident: bib4
  article-title: The Advanced Glaucoma Intervention Study (AGIS): 12
  publication-title: Am J Ophthalmol
– volume: 45
  start-page: 1823
  year: 2004
  end-page: 1829
  ident: bib17
  article-title: Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry
  publication-title: Invest Ophthalmol Vis Sci
– volume: 19
  start-page: 643
  year: 2005
  end-page: 651
  ident: bib20
  article-title: Risk factors for progressive visual field loss in primary open angle glaucoma
  publication-title: Eye (Lond)
– volume: 100
  start-page: 737
  year: 1982
  end-page: 741
  ident: bib22
  article-title: Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis
  publication-title: Arch Ophthalmol
– volume: 237
  start-page: 463
  year: 1999
  end-page: 467
  ident: bib11
  article-title: Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis
  publication-title: Graefes Arch Clin Exp Ophthalmol
– start-page: 121
  year: 1999
  end-page: 136
  ident: bib13
  article-title: Automated Static Perimetry
– volume: 108
  start-page: 1943
  year: 2001
  end-page: 1953
  ident: bib6
  article-title: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery
  publication-title: Ophthalmology
– volume: 83
  start-page: 596
  year: 1988
  end-page: 610
  ident: bib16
  article-title: Locally-weighted regression: an approach to regression analysis by local fitting
  publication-title: J Am Stat Assoc
– volume: 145
  start-page: 343
  year: 2008
  end-page: 353
  ident: bib12
  article-title: A visual field index for calculation of glaucoma rate of progression
  publication-title: Am J Ophthalmol
– volume: 53
  start-page: S3
  year: 2008
  end-page: S10
  ident: bib2
  article-title: Risk factors for glaucoma onset and progression
  publication-title: Surv Ophthalmol
– volume: 110
  start-page: 900
  year: 2003
  end-page: 907
  ident: bib10
  article-title: Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years
  publication-title: Ophthalmology
– volume: 18
  start-page: 106
  year: 2004
  end-page: 115
  ident: bib23
  article-title: Rate of visual field progression in primary open-angle glaucoma and primary angle-closure glaucoma
  publication-title: Korean J Ophthalmol
– volume: 53
  start-page: S3
  issue: suppl
  year: 2008
  ident: 10.1016/j.ophtha.2010.05.027_bib2
  article-title: Risk factors for glaucoma onset and progression
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2008.08.006
– volume: 110
  start-page: 381
  year: 1992
  ident: 10.1016/j.ophtha.2010.05.027_bib14
  article-title: Accounting for the correlation between fellow eyes in regression analysis
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1992.01080150079033
– volume: 19
  start-page: 102
  year: 2008
  ident: 10.1016/j.ophtha.2010.05.027_bib1
  article-title: Risk factors for primary open angle glaucoma progression: what we know and what we need to know
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0b013e3282f493b3
– volume: 127
  start-page: 1610
  year: 2009
  ident: 10.1016/j.ophtha.2010.05.027_bib19
  article-title: Prediction of glaucomatous visual field loss by extrapolation of linear trends
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2009.297
– volume: 83
  start-page: 596
  year: 1988
  ident: 10.1016/j.ophtha.2010.05.027_bib16
  article-title: Locally-weighted regression: an approach to regression analysis by local fitting
  publication-title: J Am Stat Assoc
  doi: 10.1080/01621459.1988.10478639
– volume: 110
  start-page: 900
  year: 2003
  ident: 10.1016/j.ophtha.2010.05.027_bib10
  article-title: Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(03)00076-9
– volume: 121
  start-page: 48
  year: 2003
  ident: 10.1016/j.ophtha.2010.05.027_bib5
  article-title: Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.121.1.48
– volume: 111
  start-page: 1627
  year: 2004
  ident: 10.1016/j.ophtha.2010.05.027_bib21
  article-title: Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2004.02.017
– volume: 237
  start-page: 463
  year: 1999
  ident: 10.1016/j.ophtha.2010.05.027_bib11
  article-title: Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s004170050262
– volume: 145
  start-page: 343
  year: 2008
  ident: 10.1016/j.ophtha.2010.05.027_bib12
  article-title: A visual field index for calculation of glaucoma rate of progression
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2007.09.038
– volume: 45
  start-page: 1823
  year: 2004
  ident: 10.1016/j.ophtha.2010.05.027_bib17
  article-title: Relationship between visual field sensitivity and retinal nerve fiber layer thickness as measured by scanning laser polarimetry
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.03-0692
– volume: 13
  start-page: 120
  year: 2004
  ident: 10.1016/j.ophtha.2010.05.027_bib9
  article-title: Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma
  publication-title: J Glaucoma
  doi: 10.1097/00061198-200404000-00007
– volume: 24
  start-page: 1426
  year: 2007
  ident: 10.1016/j.ophtha.2010.05.027_bib18
  article-title: Relating retinal nerve fiber thickness to behavioral sensitivity in patients with glaucoma: application of a linear model
  publication-title: J Opt Soc Am A Opt Image Sci Vis
  doi: 10.1364/JOSAA.24.001426
– start-page: 121
  year: 1999
  ident: 10.1016/j.ophtha.2010.05.027_bib13
  article-title: Automated Static Perimetry
– volume: 134
  start-page: 499
  year: 2002
  ident: 10.1016/j.ophtha.2010.05.027_bib4
  article-title: The Advanced Glaucoma Intervention Study (AGIS): 12
  publication-title: Am J Ophthalmol
– volume: 37
  start-page: 1419
  year: 1996
  ident: 10.1016/j.ophtha.2010.05.027_bib7
  article-title: Analysis of progressive change in automated visual fields in glaucoma
  publication-title: Invest Ophthalmol Vis Sci
– volume: 130
  start-page: 274
  year: 2000
  ident: 10.1016/j.ophtha.2010.05.027_bib3
  article-title: Factors associated with long-term progression or stability in primary open-angle glaucoma
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00487-6
– volume: 118
  start-page: 481
  year: 2000
  ident: 10.1016/j.ophtha.2010.05.027_bib8
  article-title: Rate of visual field loss in progressive glaucoma
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.118.4.481
– volume: 100
  start-page: 737
  year: 1982
  ident: 10.1016/j.ophtha.2010.05.027_bib22
  article-title: Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1982.01030030741002
– volume: 56
  start-page: 645
  year: 2000
  ident: 10.1016/j.ophtha.2010.05.027_bib15
  article-title: A note on robust variance estimation for cluster-correlated data
  publication-title: Biometrics
  doi: 10.1111/j.0006-341X.2000.00645.x
– volume: 19
  start-page: 643
  year: 2005
  ident: 10.1016/j.ophtha.2010.05.027_bib20
  article-title: Risk factors for progressive visual field loss in primary open angle glaucoma
  publication-title: Eye (Lond)
  doi: 10.1038/sj.eye.6701605
– volume: 108
  start-page: 1943
  year: 2001
  ident: 10.1016/j.ophtha.2010.05.027_bib6
  article-title: Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(01)00873-9
– volume: 18
  start-page: 106
  year: 2004
  ident: 10.1016/j.ophtha.2010.05.027_bib23
  article-title: Rate of visual field progression in primary open-angle glaucoma and primary angle-closure glaucoma
  publication-title: Korean J Ophthalmol
  doi: 10.3341/kjo.2004.18.2.106
– reference: 22214951 - Ophthalmology. 2012 Jan;119(1):203-4; author reply 204
SSID ssj0006634
Score 2.2469366
Snippet To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Clinic-based, retrospective...
Purpose To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma. Design Clinic-based,...
To evaluate the relationship between severity of visual field (VF) loss at presentation and rate of VF progression in glaucoma.PURPOSETo evaluate the...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 249
SubjectTerms Biological and medical sciences
Disease Progression
Diseases of visual field, optic nerve, optic chiasma and optic tracts
Female
Follow-Up Studies
Glaucoma and intraocular pressure
Glaucoma, Open-Angle - diagnosis
Glaucoma, Open-Angle - physiopathology
Humans
Intraocular Pressure - physiology
Male
Medical sciences
Middle Aged
Miscellaneous
Ophthalmology
Retrospective Studies
Tonometry, Ocular
Vision Disorders - diagnosis
Vision Disorders - physiopathology
Visual Field Tests
Visual Fields - physiology
Title Relationship between Severity of Visual Field Loss at Presentation and Rate of Visual Field Progression in Glaucoma
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0161642010006019
https://www.clinicalkey.es/playcontent/1-s2.0-S0161642010006019
https://dx.doi.org/10.1016/j.ophtha.2010.05.027
https://www.ncbi.nlm.nih.gov/pubmed/20728941
https://www.proquest.com/docview/849432731
Volume 118
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9pAEF5RIlWVqqrPlD6iPfSGjPxYP_ZI0hBUQhJBaHNbre21IKIGxebSn95TZ71rY-SgpLlYyJo1Xs_n2ZnxN7MIfXMd4hNOE0P2PTVI4HGDksiTpHHfsUKLR6YsTh5feMMZ-XHj3rRaf2uspU0e9qI_99aVPEWrcA70Kqtk_0Oz1UXhBPwG_cIRNAzHR-m4YrLVGVdTAfPQRIufi0yWhwwkTa17DuuhrF282lYcKSbyhCuuwI70lSRuqaYdMidytuQbmAKvO7OX63k-58vfqo1TkYvQ228pQn6a9mqJhgkvsrJDiKTnvHteWKXx98LmXRwXMOterisSTkX97oNlXPPlctGd9RpSxzzc6G8AqewkwrtnTaEpTHauUt3TxV252_S4YIAMJnoLx3ibya1IJDoX6lkGhE_mjjHfWvMqqNamWbVG1au8rVoUNxYQlcu47a2KJ6ipf27PVA0Mdvt1n56MLCOze6Yxlfcib8VSDW7orrCKtlhmM5M1RJ-hAxtCHLuNDvqjya9R5UeAL6g706tploWfBTuxeX_7HKuXa57B656ofVr2B1KFQ3X9Gr3SkRDuK1i_QS2RvkXPx5rr8Q5ldXRjjW5cohuvEqzwigu8YoluzHNcRzcGdGOJ7oZ0Dd14keIS3e_RbHB6fTI09BYhRgSRSG5Q17eSyKax41lJzKnL44A4oWV5SUC9OIYHKwQJ5d68lJuhbBYonDAhtpBxPYQfH1A7XaXiI8LcNmkgwjChMCIILO4SuAwPqIgSCCKiDnLK58si3T9fbuOyZCVR8pYprTCpFWa6DLTSQUY1aq36xzwg75aqY2VtNKzmDPD5wDj_vnEi0-YqY_vwVx-pvW7lTT_iP492sFVNUIYBfuBYHYRLsDFYteSnSJ6K1SZjAaHEgcgJRA4VCLeDTd8OKLE-PXlGn9GLrb34gtr53UZ8hdAhD4_0O_YPXV8RvA
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+Severity+of+Visual+Field+Loss+at+Presentation+and+Rate+of+Visual+Field+Progression+in+Glaucoma&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Rao%2C+Harsha+L.%2C+MD%2C+DNB%2C+B+Opt&rft.au=Kumar%2C+Addepalli+U.%2C+B+Opt&rft.au=Babu%2C+Jonnadula+G.%2C+B+Opt&rft.au=Senthil%2C+Sirisha%2C+MR%2C+FRCS&rft.date=2011-02-01&rft.issn=0161-6420&rft.volume=118&rft.issue=2&rft.spage=249&rft.epage=253&rft_id=info:doi/10.1016%2Fj.ophtha.2010.05.027&rft.externalDBID=ECK1-s2.0-S0161642010006019&rft.externalDocID=1_s2_0_S0161642010006019
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642010X00094%2Fcov150h.gif